Xilio Therapeutics Inc’s recently made public that its Chief Financial Officer Frankenfield Christopher James unloaded Company’s shares for reported $6841.0
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Xilio Therapeutics Inc’s filing revealed that its Chief Financial Officer Frankenfield Christopher James unloaded Company’s shares for reported $6841.0 on